Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 3
This trial was done to see if bortezomib can help stop diffuse large B cell lymphoma coming back after treatment. It was for people who hadn’t had treatment for their lymphoma before.
The trial was supported by Cancer Research UK.
It was open for people to join between 2011 and 2015. The team published the results in 2019 and 2023.
Recruitment start: 17 May 2011
Recruitment end: 12 June 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Johnson
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Janssen-Cilag
NIHR Clinical Research Network: Cancer
University Hospital Southampton NHS Foundation Trust
University of Southampton
This is Cancer Research UK trial number CRUKE/10/024.
Last reviewed: 3 June 2025
CRUK internal database number: 6190
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
